Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to $96.8 million.

  • Nutex Health's Income from Continuing Operations rose 145099.79% to $96.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $263.8 million, marking a year-over-year increase of 91397.52%. This contributed to the annual value of $94.8 million for FY2024, which is 31832.65% up from last year.
  • As of Q3 2025, Nutex Health's Income from Continuing Operations stood at $96.8 million, which was up 145099.79% from $16.1 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Income from Continuing Operations ranged from a high of $100.0 million in Q4 2024 and a low of -$422.9 million during Q3 2022
  • For the 5-year period, Nutex Health's Income from Continuing Operations averaged around -$5.5 million, with its median value being -$542000.0 (2024).
  • Per our database at Business Quant, Nutex Health's Income from Continuing Operations skyrocketed by 1295642.83% in 2021 and then plummeted by 66770.69% in 2022.
  • Nutex Health's Income from Continuing Operations (Quarter) stood at $13.5 million in 2021, then plummeted by 179.1% to -$10.7 million in 2022, then plummeted by 159.99% to -$27.7 million in 2023, then skyrocketed by 461.03% to $100.0 million in 2024, then fell by 3.25% to $96.8 million in 2025.
  • Its last three reported values are $96.8 million in Q3 2025, $16.1 million for Q2 2025, and $50.8 million during Q1 2025.